Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,947
Closed -$1.47M 2991
2025
Q2
$1.47M Sell
14,947
-269
-2% -$25.5K 0.01% 898
2025
Q1
$1.41M Sell
15,216
-377
-2% -$34.8K 0.01% 909
2024
Q4
$1.42M Buy
15,593
+444
+3% +$40.8K 0.01% 914
2024
Q3
$1.46M Sell
15,149
-3,371
-18% -$329K 0.01% 925
2024
Q2
$1.7M Sell
18,520
-3,438
-16% -$319K 0.01% 885
2024
Q1
$2.02M Buy
21,958
+1,574
+8% +$148K 0.02% 851
2023
Q4
$1.94M Sell
20,384
-126
-0.6% -$11.8K 0.02% 927
2023
Q3
$1.92M Sell
20,510
-679
-3% -$62.7K 0.02% 882
2023
Q2
$1.94M Sell
21,189
-1,051
-5% -$86.2K 0.02% 901
2023
Q1
$1.64M Sell
22,240
-4,859
-18% -$420K 0.01% 939
2022
Q4
$2.26M Buy
27,099
+3,919
+17% +$353K 0.02% 852
2022
Q3
$2.24M Buy
23,180
+541
+2% +$64.5K 0.02% 790
2022
Q2
$2.38M Sell
22,639
-1,416
-6% -$181K 0.02% 802
2022
Q1
$4.14M Sell
24,055
-97
-0.4% -$14.5K 0.03% 576
2021
Q4
$3.91M Buy
24,152
+727
+3% +$117K 0.03% 647
2021
Q3
$3.49M Sell
23,425
-2,411
-9% -$501K 0.03% 687
2021
Q2
$6.33M Buy
25,836
+19,594
+314% +$5.14M 0.05% 404
2021
Q1
$1.65M Sell
6,242
-519
-8% -$146K 0.06% 310
2020
Q4
$1.98M Buy
6,761
+108
+2% +$27.7K 0.08% 243
2020
Q3
$1.57M Sell
6,653
-182
-3% -$41.4K 0.07% 274
2020
Q2
$1.36M Buy
6,835
+944
+16% +$176K 0.06% 292
2020
Q1
$1.08M Sell
5,891
-188
-3% -$33.4K 0.03% 591
2019
Q4
$1.01M Buy
6,079
+274
+5% +$40.8K 0.02% 797
2019
Q3
$761K Sell
5,805
-101
-2% -$13.1K 0.02% 852
2019
Q2
$717K Buy
5,906
+1,587
+37% +$188K 0.02% 893
2019
Q1
$532K Buy
4,319
+113
+3% +$14.2K 0.01% 968
2018
Q4
$493K Buy
4,206
+2,344
+126% +$276K 0.01% 931
2018
Q3
$233K Sell
1,862
-2,805
-60% -$310K 0.01% 1246
2018
Q2
$399K Buy
4,667
+563
+14% +$41.3K 0.01% 1149
2018
Q1
$248K Sell
4,104
-64
-2% -$3.65K 0.01% 1328
2017
Q4
$220K Buy
4,168
+252
+6% +$13.3K 0.01% 1442
2017
Q3
$219K Sell
3,916
-4
-0.1% -$212 0.01% 1396
2017
Q2
$246K Buy
+3,920
New +$228K 0.01% 1306

Other funds holding AMED

Amalgamated Bank's AMED Position: Q3 2025 in Review

Amalgamated Bank sold out of Amedisys (AMED) in Q3 2025, closing a stake of 14,947 shares — an estimated $1.47M sold.

Amalgamated Bank first reported a position in AMED in Q2 2017 and held it in 33 quarters. The position peaked at $6.33M in Q2 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Amalgamated Bank reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Amalgamated Bank sold 14,947 Amedisys shares in Q3 2025, an estimated $1.47M.
  • Amalgamated Bank first reported a position in Amedisys in Q2 2017 and held it in 33 quarters.
  • Amalgamated Bank's Amedisys position peaked at $6.33M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Amalgamated Bank's 13F filing for Q3 2025, filed 29 Oct 2025.